Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease

By Lassila M.   Fukami K.   Jandeleit-Dahm K.   Semple T.   Carmeliet P.   Cooper M.   Kitching A.  

Diabetologia, Vol. 50, Iss. 6, 2007-06 ,pp. : 1315-1326

Springer Publishing Company

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibitor Prevents Plasminogen Activator Inhibitor-1 Expression in a Rat Model with Cardiovascular Remodeling Induced by Chronic Inhibition of Nitric Oxide Synthesis

By Katoh M.   Egashira K.   Mitsui T.   Chishima S.   Takeshita A.   Narita H.  

Journal of Molecular and Cellular Cardiology, Vol. 32, Iss. 1, 2000-01 ,pp. : 73-83

Academic Press

Access to resources Recommend Favorite

Molecular Advances in Plasminogen Activator Inhibitor 1 Interaction with Thrombin and Tissue-Type Plasminogen Activator

By Stoop A.   van Meijer M.   Horrevoets A.J.G.   Pannekoek H.  

Trends in Cardiovascular Medicine, Vol. 7, Iss. 2, 1997-02 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite

Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome

By Lindholm Åsa   Bixo Marie   Eliasson Mats   Hudecova Miriam   Arnadottir Ragnheidur   Holte Jan   Poromaa Inger Sundström  

Gynecological Endocrinology, Vol. 26, Iss. 10, 2010-10 ,pp. : 743-748

Informa Healthcare

Access to resources Recommend Favorite

Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models

By Hagiwara H.   Kaizu K.   Uriu K.   Noguchi T.   Takagi I.   Qie Y.L.   Seki T.   Ariga T.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 301-309

Elsevier

Access to resources Recommend Favorite